14th Annual Asthma and Allergy Conference


2019 Educational Objectives

Conference educational objectives are to recognize, discuss and debate the following:


  • Understand the various ways in which patients encounter allergy-related misinformation online.
  • Understand the origins surrounding misconceptions specific to allergic conditions.
  • Anticipate and actively address patient confusion and misinformation during clinical encounters.
  • Determine if immunoglobulin E (IgE, a type of antibody) testing is indicated based on important elements in a patient’s clinical history.
  • Avoid using indiscriminate panels of food allergen IgE tests when evaluating patients.
  • Understand why IgE results are often falsely elevated.
  • Recognize skin prick and serum IgE test limitations in diagnosing food allergy.
  • Understand how food challenges help to diagnose food allergy, as well as to determine if a patient has developed a tolerance to a previously diagnosed food allergy.
  • Incorporate shared decision making when discussing risks and benefits of oral food challenges with patient and families.

Asthma / Respiratory

  • Understand biologic agent mechanisms of action and indications in upper and lower airway disease.
  • Differentiate chronic rhinosinusitis from other causes of head and facial pain by demonstrating inflammation in the nose and paranasal sinuses.
  • Understand the different etiologies of chronic sinusitis and how treatment differs depending on cause.
  • Learn how to perform spirometry as a common test to assess lung function.
  • Understand the role spirometry can play in managing asthma.
  • Learn how to interpret spirometry.
  • Understand the varied determinants of persistent childhood asthma.
  • Use the Pediatric Asthma Yardstick to assess and guide step-up therapy in childhood asthma.
  • Distinguish when constant versus intermittent therapy is appropriate in children with mild asthma.

Immune System

  • Describe the typical presentation of patients with common variable immunodeficiency (CVID) including the autoimmunity and inflammatory features that can accompany this diagnosis.
  • Explain approaches to diagnose and treat complications of CVID.
  • Describe an approach to CVID genetic testing that accounts for the clinical presentation and therapeutic options.
  • Recognize clinical patterns of common primary immunodeficiency diseases (PIDD).
  • Learn how to initiate and interpret PIDD screening laboratory studies.
  • Recognize PIDD treatment modalities, dilemmas and strategies.
  • Understand Immune-mediated adverse drug reactions as an uncommon but potentially life-threatening occurrence.
  • Review presentation of drug reaction with eosinophilia and systemic symptoms (DRESS); Stevens-Johnson syndrome (SJS) and Toxic epidermal necrolysis (TEN).
  • Identify culprit medication and risk factors for adverse drug reactions.


  • Identify when to refer a patient for penicillin allergy testing.
  • Understand the importance of clearing a patient of penicillin allergy label.
  • Define and understand the importance of antibiotic stewardship.
  • Identify three common opportunities for antibiotic stewardship.
  • Describe three common toxicities or side effects of antibiotic treatment.

Skin / Swelling

  • Describe the symptoms and causes of atopic dermatitis (eczema).
  • Determine an approach to evaluating and treating severe atopic dermatitis.
  • Understand the role and importance of allergy testing in atopic dermatitis.
  • Review the Atopic Dermatitis Yardstick, a series of practical treatment recommendations incorporating the latest research and therapies.
  • Identify urticaria and angioedema phenotypes, the characteristics determined by genetic and environmental influences.
  • Recognize urticaria and angioedema clinical manifestations.
  • Explain proper management of urticaria and angioedema patients.
  • Implement updated urticaria and angioedema treatment guidelines.